Clarissa Sowemimo-Coker CEO: RNS Clarissa appointed CEO permanently plus Programme updates

Video

12 Apr

Written By Rob Bennett

Rob Bennett https://www.octavianrx.com

Clinical Biomarkers & CDx Conference Europe 2023

Clarissa Sowemimo-Coker CEO: Update on CTA Phase 1, MHRA approval process